Skip to main content

Articles

Page 2 of 12

  1. Malnutrition is associated with discontinuing peritoneal dialysis (PD). The prognostic nutritional index (PNI), composed of serum albumin level and total lymphocyte count, has been suggested as a prognostic ma...

    Authors: Yoshikazu Miyasato, Jun Morinaga, Hideki Inoue, Yushi Nakayama, Masataka Adachi, Yuichiro Izumi, Yutaka Kakizoe, Teruhiko Mizumoto, Terumasa Nakagawa, Daisuke Fujimoto, Makoto Ono, Akira Oda, Takashige Kuwabara and Masashi Mukoyama
    Citation: Renal Replacement Therapy 2023 9:58
  2. Renal ischemia/reperfusion injury is an unavoidable event in transplantation in which free radical-mediated injury determines release of pro-inflammatory cytokines and activation of innate immunity. In additio...

    Authors: Giacomo Cusumano, Edoardo Cola, Gionata Spagnoletti, Anna Severino, Simona Giubilato, Egidio Stigliano, Maria Emiliana Caristo, Gisella Vischini, Giovanna Liuzzo, Maria Paola Salerno, Filippo Crea and Jacopo Romagnoli
    Citation: Renal Replacement Therapy 2023 9:57
  3. Latent tuberculosis infection (LTBI) affects 11.9% of outpatients under maintenance hemodialysis in Japan. In addition, the risk of reactivation of LTBI in hemodialysis patients is up to 10–25 times higher tha...

    Authors: Masataro Toda, Ayumi Yoshifuji, Koji Hosoya, Motoaki Komatsu, Naoki Hasegawa and Munekazu Ryuzaki
    Citation: Renal Replacement Therapy 2023 9:56
  4. Empirical antibiotic treatment against peritoneal dialysis (PD)-related peritonitis should be immediately initiated before PD effluent culture results are obtained. As culture results guide the choice of antib...

    Authors: Hisato Shima, Takuya Okamoto, Manabu Tashiro, Tomoko Inoue, Seiichiro Wariishi, Hiroyasu Bando, Hiroyuki Azuma, Naohito Iwasaka, Takuji Ohara, Toshio Doi, Kazuyoshi Okada and Jun Minakuchi
    Citation: Renal Replacement Therapy 2023 9:55
  5. Coronavirus disease (COVID-19) continues to be prevalent in 2023, and infection control measures against it remain important in medical practice. In 2020, we conducted a questionnaire survey mainly on the impl...

    Authors: Toyohiro Hashiba, Yuka Suagawara, Masao Iwagami, Tomoyuki Yamakawa, Munekazu Ryuzaki, Kan Kikuchi, Takashi Kadowaki and Masaomi Nangaku
    Citation: Renal Replacement Therapy 2023 9:54
  6. Tumor lysis syndrome is an oncological emergency triggered by the rapid release of intracellular materials from lysed malignant cells. Intensive chemotherapy is challenging for patients with severe renal dysfu...

    Authors: Takahiro Kawaji, Akinao Okamoto, Kazuhiro Moriyama, Seiko Hayakawa, Akihiro Tomita, Yoshitaka Hara, Naohide Kuriyama, Tomoyuki Nakamura and Osamu Nishida
    Citation: Renal Replacement Therapy 2023 9:53
  7. Foreign body-induced acute appendicitis is rare but could most often be caused by fish bones; those caused by endoscopic clips are highly rare. Herein, we report a case of acute appendicitis caused by endoscop...

    Authors: Daichi Yomogida, Yuhei Fujisawa, Akari Takeji, Yasuhito Takeda, Yoshiharu Tomita and Yukihiro Shirota
    Citation: Renal Replacement Therapy 2023 9:52
  8. Fat embolism syndrome (FES) is a rare syndrome that typically occurs 12–72 h after long bone or pelvic fractures with a classic triad of respiratory distress, neurologic changes, and petechial rash. Although G...

    Authors: Takuya Suda, Hiroshi Fujii, Keita Asakura, Makoto Horita, Ryo Nishioka, Takahiro Koga, Yasuhiro Myojo, Akikatsu Nakashima and Mitsuhiro Kawano
    Citation: Renal Replacement Therapy 2023 9:51
  9. Fechtner syndrome, also referred to as nonmuscle myosin heavy chain 9-related disease (MYH9-RD), is an autosomal-dominant genetic disorder. It is caused by abnormalities in the MYH9 gene, which encodes the non...

    Authors: Eriko Yoshida Hama, Shintaro Yamaguchi, Kiyotaka Uchiyama, Daiki Kojima, Tomoki Nagasaka, Norifumi Yoshimoto, Takaya Tajima, Takeshi Kanda, Kohkichi Morimoto, Tadashi Yoshida, Kenjiro Kosaki, Hiroshi Itoh and Kaori Hayashi
    Citation: Renal Replacement Therapy 2023 9:50
  10. Hepatitis C virus (HCV) infection is linked to a higher mortality rate in hemodialysis (HD) patients. We aimed to see if HCV eradication using interferon-free direct acting antivirals (DAAs) can affect bone-mi...

    Authors: Mahmoud M. Elnokeety, Rasha Ahmed Darwish, Mohamed Tharwat Hegazy, Sameh Abouzeid and Ahmed Fayed
    Citation: Renal Replacement Therapy 2023 9:49
  11. Given rapid aging of the global population, preventing adverse events such as falls is essential for preserving functional capacity and quality of life among older adults, especially those at high risk due to ...

    Authors: Hiroki Yabe, Tomoya Yamaguchi, Kenichi Kono, Aiko Sakakibara, Hiroko Sugimoto, Yumiko Ishikawa, Yoshiko Yamaguchi and Hisanori Azekura
    Citation: Renal Replacement Therapy 2023 9:48
  12. The Japanese Society for Dialysis Therapy is conducting the survey annually since 1968. The results provide a comprehensive picture of dialysis therapy in Japan. The survey for the year 2019 was performed as o...

    Authors: Norio Hanafusa, Masanori Abe, Nobuhiko Joki, Tetsuya Ogawa, Eiichiro Kanda, Kan Kikuchi, Shunsuke Goto, Masatomo Taniguchi, Shigeru Nakai, Toshihide Naganuma, Takeshi Hasegawa, Junichi Hoshino, Kenichiro Miura, Atsushi Wada and Yoshiaki Takemoto
    Citation: Renal Replacement Therapy 2023 9:47
  13. Although transcatheter aortic valve implantation (TAVI) is assumed to be a less invasive therapy in high-risk patients with aortic valve stenosis (AS), there have been limited data suggesting its beneficial ef...

    Authors: Masahiro Sakai, Koichi Hayashi, Yuki Hara, Akihiro Miyake, Keisuke Takano, Taro Hirai, Michi Kobayashi, Keita Endo, Kaede Yoshino, Koichi Kitamura, Shinsuke Ito, Tatsuya Ikeda, Yasuhiro Suzuki, Joji Ito, Kotaro Obunai, Hiroyuki Watanabe…
    Citation: Renal Replacement Therapy 2023 9:46
  14. Acute kidney injury (AKI) is an emerging public health problem worldwide and is associated with high morbidity and mortality. The high mortality rate can be attributed to the lack of pharmacological therapies ...

    Authors: Shigeo Negi, Tatsuya Wada, Naoya Matsumoto, Jun Muratsu and Takashi Shigematsu
    Citation: Renal Replacement Therapy 2023 9:45
  15. Compassionate care is one of the concepts that is important to the care of patients with chronic diseases, especially for patients undergoing hemodialysis who deal with all kinds of problems and sufferings. Th...

    Authors: Shayan Nikpey, Mansour Ghafourifard and Akram Ghahramanian
    Citation: Renal Replacement Therapy 2023 9:43
  16. Propofol is commonly used for sedation in the Intensive Care Unit (ICU). When administered in high doses and for a prolonged time, it can cause a rare but hazardous complication: Propofol Infusion Syndrome (PR...

    Authors: Marjorie Gosdal Zambon, Luana Caroline Miantti Ghellere Bonfim, Isadora Schwaab Guerini and Marcela de Almeida Lopes
    Citation: Renal Replacement Therapy 2023 9:42
  17. Alactic base excess (ABE) is a novel biomarker that estimates the renal capability of handling acid–base alterations during the sepsis. Hence, the aim of this study was to evaluate the use of ABE to predict th...

    Authors: Jesús S. Sánchez Díaz, Karla Gabriela Peniche Moguel, Fabiola Buelna Gaxiola, José M. Reyes Ruiz, Orlando R. Pérez Nieto and María V. Calyeca Sánchez
    Citation: Renal Replacement Therapy 2023 9:41
  18. Walking ability is an important prognostic factor for patients undergoing maintenance hemodialysis (HD). Since complications such as poor nutrition, anemia, malnutrition, and inflammation in patients undergoin...

    Authors: Hiroki Yabe, Haruka Nakano, Tomoya Yamaguchi, Ren Takahashi, Kenichi Kono, Yoshifumi Moriyama and Tetsuya Yamada
    Citation: Renal Replacement Therapy 2023 9:40
  19. Hemodialysis-associated pruritus (HAP) occurs in 60–80% of hemodialysis patients. This significant complication not only decreases quality of life through sleep disturbance and depression, but also leads to po...

    Authors: Naoko Takahashi, Jun Mano, Kenta Uchida, Taku Yoshizawa, Junko Kumagai, Hideki Kawanishi, Shinichiro Tsuchiya, Misaki Moriishi and Takao Masaki
    Citation: Renal Replacement Therapy 2023 9:39
  20. Hemodialysis patients have chronic kidney disease, are often elderly, and have many complications such as hypertension, type 2 diabetes, cardiac disease, and cerebrovascular disease. Therefore, hemodialysis pa...

    Authors: Ryoichi Miyazaki, Kyoko Miyagi, Misaki Yoshida, Yasunori Suzuki and Shinya Hibino
    Citation: Renal Replacement Therapy 2023 9:38
  21. Therefore, reports on the risk of HTLV-1-related diseases in organ transplantation have increased in recent years, and the management of HTLV in renal transplantation remains a challenge.

    Authors: Noriaki Kawano, Yamada Kyohei, Hiroaki Miyoshi, Noriaki Yoshida, Kouichi Ohshima, Fumiko Arakawa, Kazutaka Nakashima, Takuro Kameda, Yasunori Kogure, Yuta Ito, Shuro Yoshida, Takuro Kuriyama, Takashi Nakaike, Taro Tochigi, Ken Takigawa, Kiyoshi Yamashita…
    Citation: Renal Replacement Therapy 2023 9:36
  22. The weakened immune system of patients on hemodialysis (HD) may prolong SARS-CoV-2 infection compared to the general population. Current international guidelines recommend ending isolation in conjunction with ...

    Authors: Gaetano Alfano, Niccolò Morisi, Camilla Ferri, Francesco Fontana, Silvia Giovanella, Giulia Ligabue, Giacomo Mori, Erica Franceschini, Annachiara Ferrari, Mariacristina Gregorini, Gianni Cappelli, Sara Tagliazucchi, Monica Pecorari, Giovanni Guaraldi, Riccardo Magistroni and Gabriele Donati
    Citation: Renal Replacement Therapy 2023 9:35
  23. Preventing peritoneal dialysis (PD)-associated peritonitis remains a major concern in continuing safe treatment and improving patient quality of life. This study aimed to determine the self-care education and ...

    Authors: Haruna Kugai, Ayumi Igarashi, Saori Anezaki, Chie Fukui, Nami Saito, Yoshifumi Hamasaki and Noriko Yamamoto-Mitani
    Citation: Renal Replacement Therapy 2023 9:34
  24. When polymethyl methacrylate (PMMA) membranes are used in continuous renal replacement therapy, especially in patients with high cytokine levels, inflammatory cytokines and other substances are removed by the ...

    Authors: Yoshitaka Kurihara, Kenichi Kokubo, Yuta Kobayashi, Yosuke Ushiroda, Shunichi Ueki, Hiroshi Tsukao, Kozue Kobayashi, Masaru Kubota and Hirosuke Kobayashi
    Citation: Renal Replacement Therapy 2023 9:33
  25. Survival is equivalent between super high-flux hemodialysis (SHF-HD) and online hemodiafiltration (OHDF) with similar albumin leakage. According to the 2013 Japanese dialyzer performance classification, surviv...

    Authors: Kazuyoshi Okada, Manabu Tashiro, Hiroyuki Michiwaki, Tomoko Inoue, Hisato Shima, Jun Minakuchi and Shu Kawashima
    Citation: Renal Replacement Therapy 2023 9:32
  26. In 2022, the government approved the telemedicine system for peritoneal dialysis (PD) in Japan in the form of medical fees. In 2000, we completed a telemedicine system for PD using an automatic peritoneal dial...

    Authors: Hidetomo Nakamoto, Ryutaro Aoyagi, Takeru Kusano, Takehito Kobayashi and Munekazu Ryuzaki
    Citation: Renal Replacement Therapy 2023 9:31
  27. Approximately 340,000 people in Japan are on chronic dialysis, and this number continues to increase. Even today, hemodialysis is the most frequently selected modality for renal replacement therapy in Japan, a...

    Authors: Yuki Kawaguchi, Norio Hanafusa and Ken Tsuchiya
    Citation: Renal Replacement Therapy 2023 9:29
  28. Clarification of the factors associated with decreased physical activity is crucial for effective disease management in patients undergoing hemodialysis. Although evidence suggests that physical activity may b...

    Authors: Yusuke Matsunaga, Yuta Suzuki, Shohei Yamamoto, Keigo Imamura, Shun Yoshikoshi, Manae Harada, Toshiki Kutsuna, Kentaro Kamiya, Atsushi Yoshida, Kanako Ichikura, Yuko Fukase, Norio Murayama, Hirokuni Tagaya and Atsuhiko Matsunaga
    Citation: Renal Replacement Therapy 2023 9:28
  29. In accordance with the United Nations' 2030 Agenda for Sustainable Development and Japan's Diet Members Caucus on Global Health, we prepared a report and recommendations for nephrology nursing care in the cont...

    Authors: Nadami Mimura, Yoshiko Takuwa, Yui Tamura, Harumi Kawamura, Misato Nishimura and Noriko Yamaguchi
    Citation: Renal Replacement Therapy 2023 9:27
  30. Pediatric continuous kidney replacement therapy (CKRT) uses blood as the priming fluid in the CKRT circuit to prevent hemodilution and hypotension and is dialyzed using a dialysate before the start of CKRT. Th...

    Authors: Hiroyuki Nagafuchi, Kenta Shono, Hiroyuki Shimizu, Kaori Yamada, Aya Kajihama, Sakura Minami and Kyosuke Sasaki
    Citation: Renal Replacement Therapy 2023 9:26
  31. Plasma exchange (PEX) has been the primary treatment for immune-mediated thrombotic thrombocytopenic purpura (iTTP) since the 1990s. Daily PEX is recommended in international guidelines, but PEX was only reimb...

    Authors: Yuji Yamada, Hiroyuki Ohbe, Hideo Yasunaga, Hidetomo Nakamoto and Yoshitaka Miyakawa
    Citation: Renal Replacement Therapy 2023 9:25
  32. Heart failure is a clinical syndrome with considerable morbidity and mortality rates. Recent data published by National Health and Nutrition Examination Survey (NHANES) showed that 6 million Americans are diag...

    Authors: Aneeqa Javed, Muhammad Junaid Alvi, John Afif, Suzanne Elsayegh, Syeda Sahra and Elie El-Charabaty
    Citation: Renal Replacement Therapy 2023 9:24
  33. Hemodiafiltration (HDF) therapy has become standard treatment in Japan and Europe, but evidence from Europe is not directly applicable to HDF in Japan because HDF therapy differs greatly in the two regions. Ja...

    Authors: Toshihide Naganuma, Yoshiaki Takemoto, Naohiro Kamada and Hideki Kawanishi
    Citation: Renal Replacement Therapy 2023 9:23
  34. CCE is a systemic disease with poor prognosis with no established treatment. Approximately 23–32% of CCE cases progress to end-stage renal failure, and the 1-year mortality rate of CCE with organ failure is 60...

    Authors: Yumiko Kawai, Chiharu Kinoshita, Koichi Matsuda, Keiko Takeuchi, Yoshimoto Inoue and Yoko Fujita
    Citation: Renal Replacement Therapy 2023 9:22
  35. Although the angiotensin receptor-neprilysin inhibitor sacubitril-valsartan has demonstrated a valuable effect on cardiac function in patients with heart failure with a reduced ejection fraction, the effect of...

    Authors: Shoichiro Daimon, Yuka Sakamoto, Miyuki Yasuda and Mitsuhiro Nishitani
    Citation: Renal Replacement Therapy 2023 9:19
  36. Stenotrophomonas maltophilia (S. maltophilia) is being increasingly recognized as an important cause of nosocomial infections, particularly in immunocompromised patients, such as patients undergoing dialysis. S. ...

    Authors: Hisato Shima, Takuya Okamoto, Manabu Tashiro, Tomoko Inoue, Maho Iwaki, Seiichiro Wariishi, Kazuyoshi Okada, Toshio Doi and Jun Minakuchi
    Citation: Renal Replacement Therapy 2023 9:18
  37. End-stage renal disease (ESRD) is serious global public health challenge in many developing countries. Treatment of ESRD is carried out through renal replacement therapy like peritoneal dialysis (PD). Depressi...

    Authors: Sepehr Bazazzadeh, Mohammad Reza Sharbafchi, Maryam Kazemi Naeini, Sayed Mohsen Hosseini, Abdolamir Atapour and Mojgan Mortazavi
    Citation: Renal Replacement Therapy 2023 9:17
  38. Autism spectrum disorder (ASD) is a common communication disorder, with an incidence rate of 3%. In most cases, clinicians can diagnose ASD in a single outpatient visit. However, in the case of ASD patients wi...

    Authors: Yuko Fujii, Hideki Matsumura, Akihiko Shirasu, Hyogo Nakakura, Satoshi Yamazaki, Tetsufumi Kanazawa, Nanako Saito, Hajime Hirano, Haruhito Azuma, Kandai Nozu and Akira Ashida
    Citation: Renal Replacement Therapy 2023 9:16
  39. As there is no established standard of care for non-tuberculous mycobacterium (NTM) peritoneal dialysis (PD)-related peritonitis, its treatments have to be case-dependent, which is often difficult. Additionall...

    Authors: Tomoki Nagasaka, Kiyotaka Uchiyama, Ryoichi Shirai, Ryunosuke Mitsuno, Tomomi Maruki, Eriko Yoshida Hama, Erina Sugita, Ei Kusahana, Rena Sumura, Takashin Nakayama, Satoshi Kinugasa, Kohkichi Morimoto, Yoshitaka Ishibashi, Naoki Washida and Hiroshi Itoh
    Citation: Renal Replacement Therapy 2023 9:15
  40. The spread of coronavirus disease 2019 (COVID-19) has dramatically altered the lifestyles of many people worldwide. Several studies reported that body weight of young adults increased during the COVID-19 pande...

    Authors: Narumi Fukuzaki, Yuta Suzuki, Juri Uchida, Takuya Nakajima, Shohei Yamamoto, Keigo Imamura, Shun Yoshikoshi, Manae Harada, Ryota Matsuzawa, Kentaro Kamiya and Atsuhiko Matsunaga
    Citation: Renal Replacement Therapy 2023 9:12
  41. That the prevalence of low triiodothyronine (T3) syndrome is high among hemodialysis (HD) patients has been previously established. Herein, we examined the association of glycated albumin (GA) and the GA to gl...

    Authors: Keiji Mimura, Takahiro Nishide, Toshihide Naganuma, Yui Katsube, Seiji Ishitani, Katsuhiko Nakahara, Naohisa Hirasaka, Rie Mizobata, Yuko Yamagata, Osamu Nishikawa and Susumu Yukawa
    Citation: Renal Replacement Therapy 2023 9:11
  42. Haemodialysis (HD) patients are at increased risk of frailty, sarcopenia and protein energy wasting, all associated with increased mortality. Most of the dialysis day is taken up with travelling to and from di...

    Authors: Andrew Davenport
    Citation: Renal Replacement Therapy 2023 9:10
  43. Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare disorder characterized by asthma, eosinophilia, and systemic vasculitis. Renal involvement is not regarded as a prominent feature and the treatmen...

    Authors: Ryuichi Yoshii, Kengo Kajiwara, Naomichi Uemura, Koki Matsushita, Tomohumi Nakamura, Masao Tomita and Masashi Mukoyama
    Citation: Renal Replacement Therapy 2023 9:9

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 0.9
    5-year Journal Impact Factor: N/A
    Source Normalized Impact per Paper (SNIP): 0.530
    SCImago Journal Rank (SJR): 0.315

    Speed 2023
    Submission to first editorial decision (median days): 10
    Submission to acceptance (median days): 138

    Usage 2023
    Downloads: 545,038
    Altmetric mentions: 139